EQS News EQS News
News
Feed
Events
Feed
News
+ Events
Feed

Recently viewed news

Recently viewed Companies

Search Results of news

Show all

Search Results of Companies

Show all

Search Results of events

Show all
News Feed My Watchlists News Latest Reports Latest Research My favorite News
Events Feed Past Events Upcoming Webcasts Past Webcasts My favorite Events
Log in/Register
en

Recently viewed news

Recently viewed Companies

Search Results of news

Show all

Search Results of Companies

Show all

Search Results of events

Show all

Formycon AG

  • ISIN DE000A1EWVY8
  • Country Deutschland

Latest Research

News Functions

Additional Functions

1 October 2024

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy

19 August 2024

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy

13 June 2024

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy

21 August 2023

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy

23 September 2022

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

7 September 2022

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

30 August 2022

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

14 April 2022

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy

23 September 2021

Research

Formycon AG

Research

Original-Research: Formycon (von First Berlin Equity Research GmbH): Kaufen

5 July 2021

Research

Formycon AG

Research

Original-Research: Formycon (von First Berlin Equity Research GmbH): Hinzufügen

20 May 2021

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

26 March 2021

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Hinzufügen

7 January 2021

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

14 October 2020

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

24 September 2020

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

23 June 2020

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

19 May 2020

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

26 March 2020

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

7 February 2020

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

11 November 2019

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

7 June 2019

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

27 March 2019

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

22 November 2018

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

14 September 2018

Research

Formycon AG

Research

Original-Research: Formycon (von First Berlin Equity Research GmbH): Kaufen

6 June 2018

Research

Formycon AG

Research

Original-Research: Formycon (von First Berlin Equity Research GmbH): Kaufen

8 May 2018

Research

Formycon AG

Research

Original-Research: Formycon (von First Berlin Equity Research GmbH): Kaufen

3 May 2018

Research

Formycon AG

Research

Original-Research: Formycon (von First Berlin Equity Research GmbH): Kaufen

2 October 2017

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): BUY

29 August 2017

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): BUY

4 May 2017

Research

Formycon AG

Research

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): BUY

Latest News

News Functions

Additional Functions

4 November 2024

06:30 Corporate

Formycon AG

Corporate

Formycon applies for admission to the Prime Standard of the Frankfurt Stock Exchange

16 October 2024

06:50 Corporate

Formycon AG

Corporate

Formycon published results of analytical similarity study of biosimilar candidate FYB206 and Keytruda® in peer-reviewed journal Drugs in R&D

30 September 2024

07:30 Corporate

Formycon AG

Corporate

Formycon and Fresenius Kabi receive FDA approval for FYB202/ OtulfiTM (ustekinumab-aauz)

27 September 2024

21:56 Ad-hoc

Formycon AG

Ad-hoc

FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
09:00 Corporate

Formycon AG

Corporate

Formycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases

17 September 2024

06:50 Corporate

Formycon AG

Corporate

Formycon will present clinical data on its ustekinumab biosimilar candidate FYB202 at the EADV Congress in Amsterdam and the UEG Week in Vienna
More News

Upcoming Events

Event Functions

Additional Functions

25

Nov 24

Formycon AG

Analysts’ Conference

Frankfurt am Main

Nov

2024

Formycon AG

Press Release – quarterly statement (call-date Q3)

Martinsried/Planegg
More Events

Latest Reports

News Functions

Additional Functions

22 October 2024

Quarterly Report PDF

Formycon AG

Quarterly Report
PDF

Half-yearly financial statements 2024

29 April 2024

Annual Report PDF

Formycon AG

Annual Report
PDF

Annual financial statements 2023

30 August 2023

Quarterly Report PDF

Formycon AG

Quarterly Report
PDF

Half-yearly financial statements 2023
More Reports
Language (EN)
Legal Notice Data Protection